Produits de Maillard et complications chroniques du diabète sucré

Annales de Biologie Clinique

Volumn 57, Issue 4, 1999, Pages 445-454

  Trivin, F ^a   Chevenne, D ^a   Hautecouverture, M ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ARTERIOSCLEROSIS; BLOOD; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; GLYCATION; GLYCOSYLATION; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ARTERIOSCLEROSIS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; GLUCOSE; GLYCOSYLATION; HUMANS; MAILLARD REACTION;

EID: 0033161130     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Brownlee M, Cerami A, VIassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. A' EnglJMed 1988; 318: 1315-21.
2. Kuzuya M, Satake S, Ai S, et al. Inhibition of angiogenesis on glycated collagen lattices. Diabetologia 1998 ; 41 : 491-9.
3. Graier WF, Kostner GM. Glycated low-density lipoprotein and atherogenesis : the missing link between diabetes mellitus and hypercholesterolaemia ? Eur J Clin Invest 1997 ; 27 : 457-9.
4. Monnier VM, Glomb M, Elgawish A, Sell DR. The mechanism of collagen cross-linking in diabetes. A puzzle nearing resolution. Diabetes 1996"; 45 (suppl. 3):S67-71.
5. Booth AA, Khalifah RG, Todd P, Hudson BG. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). J Biol Chem 1997 ; 272 : 5430-7.
6. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997 ; 46 (suppl. 2) : S19-25.
7. Coppack S. Diabetes mellitiis in clinical biochemistry. Marschall WJ, Bingeard Churchill Levingston 1995 pages 257 à280.
8. Suzuki M, Ikebuchi M, Shinozaki K, et al. Mechanism and clinical implication of insulin resistance syndrome. Diabetes 1996 ; 45 (suppl. 3) : S52-4.
9. Vlassara H. Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 1994 ; 124 : 19-30.
10. Cillery P, Guillemin C, Delpech M. Hémoglobine glyquée : méthodes de dosage et problèmes de standardisation. Ann Biol Clin 1994:52: 157-63.
11. Dyer DG, Dünn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993:91 :2463-9.
12. Miyata T, Ueda Y, Shinzato T, et al. Accumulation of albumin-linked and free-form pentosidine in the circulation of urémie patients with end-stage renal failure : renal implications in the pathophysiology of pentosidine. y Am Soc Nephrol 1996 ; 7 : 1198-206.
13. Klein RL, Laimins M, Lopes-Virelle MR Isolation, caracterization, and metabolism of the glycated and non-glycated subfraction of low density lipoproteins isolated from type 1 diabetic patients and non diabetics. Diabetes 1995 ; 94 : 1093-8.
14. Calvo C, Ulloa N, Campos M, Verdugo C, Ayrault-Jarrier M. The preferential site of non-enzymatic glycation of human apolipoprotein AI m vivo. Clinica Chimica Acta 1993 ; 217 : 193-8.
15. Wang X, Bucala R, Milne R. Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products. Proc Natl Acad Sci 199S ; 95 : 7643-7.
16. Harano Y, Kageyama A, Nakao Y, et al. Diabetes 1996; 45 (suppl. 3): S31-4.
17. Rodriguez-Segade S, Camina MF, Paz JM, Del Rio R. Abnormal serum immunoglobulin concentrations in patients with diabetes mellitus. Clinica Chimica Acta 1991 ; 203 : 135-42.
18. Amore A, Cirina P, Mitola S, et al. Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney International 1997 ; 51 : 27-35.
19. Fryet EB, Degenhardt TP, Thorpe SR, Baynes JW. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J Biol Chem 1998 ; 273 : 18714-9.
20. Niwa T, Katsuzaki T, Miyazaki S, et al. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest 1997 ; 99 : 1272-80.
21. Bobbink IWG, de Boer HC, Tekelenburg WLH, Banga JD, de Groot PG. Effect of extracellular matrix glycation on endothelial cell adhesion and spreading. Involvement of vitronectin. Diabetes 1997 ; 46 : 87-93.
22. Odetti P, Aragno I, Garibaldi S, Valentin! S, Pronzato MA, Rolandi R. Role of advanced glycation end products in aging collagen. Gerontology 1998;44: 187-91.
23. Lee T, Kimigar M, Pinauto SJ, Chichester CO. Prog Food Nutri Sc 1981 ; 5 : 243-56.
24. Monnier VM, Sell DR, Miyata S, Nagaraj RH, Odelti P, Lapolla Annuziata. Advanced Maillard reaction products as markers for tissue damage in diabetes and uraemia : relevance to diabetic nephropathy. Acta Diabetol 1992 ; 29 : 130-5.
25. Degenhardt TP, Grass L, Reddy S, Thorpe SR, Damandis EP, Baynes JW. The serum concentration of the advanced glycation endproduct NE-(carbocymethyl)lysine is increased in uremia. Kidney International 1997; 52: 1064-7.
26. Yu PH, Zuo DM. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity : implications for advanced glycation and diabetic complications. Diabetologie 1997 ; 40: 1243-50.
27. Taniguchi N, Kaneto H, Asahi M, et al. Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes 1996 ; 45 (suppl. 3):S81-3.
28. Winocour PD, Watala C, Rathbone-Kinlough RL. Reduced membrane fluidity and increased glycation of membrane proteins of platelets from diabetic subjects are not associated with increased platelet adherence to glycated collagen. J Lab Clin Med 1992 ; 120 : 921-8.
29. Kashiwagi A, Asahina T, Nishio Y, et al. Glycation, oxidative stress, and scavenger activity. Glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes 1996 ; 45 (suppl. 3) : S84-6.
30. Horiuchi S, Higashi T, Ikeda K, et al. Advanced glycation end products and their recognition by macrophage and macrophage-derived cells. Diabetes 1996 ; 45 (suppl. 3) : S73-6."
31. Schmidt AM, Hori O, Cao R, et al. Rage. A novel cellular receptor for advanced glycation end products. Diabetes 1996 ; 45 (suppl. 3) : S77-80.
32. Bierhaus A, Illmer T, Kasper M, et al. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on Rage. Circulation 1997 ; 96 : 2262-71.
33. Vlassara H, Bucala R. Recent progress in advanced glycation and diabetic vascular disease : role of advanced glycation end product receptors. Diabetes 1996 ; 45 (suppl. 3) : S65-6.
34. Abordo. Immunology Lettres 1997 ; 58 : 139-47.
35. Bierhaus A, Chevion S, Chevion M, el al. Advanced glycation end product-induced activation of NF-KB is suppressed by a-lipoic acid in cultured endothelial cells. Diabetes 1997 ; 46 : 1481-90.
36. Morigi M, Angioletti S, Imberti B, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-KB-dependent fashion. J Clin Invest 1998 ; 101 : 1905-15.
37. Miyata T, Ueda Y, Horie K, et al. Renal catabolism of advanced glycation end products : the fate of pentosidine. Kidney International 1998:53:416-22.
38. Miyata T, Ueda Y, Yoshida A, et al. Clearance of pentosidine, and advanced glycation end product, by different modalities of renal replacement therapy. Kidney International 1997 ; 51 : 880-7.
39. Miyata T, Taneda S, Kawais R, et al. Identification of pentosidine as a native structure for advanced glycation end products in 2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. ProcNatlAcadSci 1996 ; 93 : 2353-8.
40. Koschinsky T, He CJ, Mitsuhashi T, et al. Orally absorbed reactive glycation products (glycotoxins) : an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci 1997 ; 94 : 6474-9.
41. Nakamura S, Makita Z, Ishikawa S, et al. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes 1997 ; 46 : 895-9.
42. Horie K, Miyata T, Maeda K, et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. J Clin Invest 1997 ; 100: 2995-3004.
43. Makita Z, Radoff S, Rayfield EJ, et al. Advanced glycosylation end products in patients with diabetic nephropathy. W Engl J Med 1991 ; 325:836-41.
44. Requena JR, Ahmed MU, Fountain CW, et al. Carboxymethylethanolaminc, a biomarkerof phospholipid modification during the Maillard reaction in vivo. J Biol Cliem 1997 ; 272 : 17473-9.
45. The Diabetes Control and Complications Trial Resarch Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependant diabetes mellitus. Arch Ophlalmol 1995 ; 113:36-51.
46. Adamis AP, Shima DT, Tolentino M, et al. Inhibition of VEGF prevents retinal ischemia-asociated iris neovascularisation in a primate. Arch Ophtalmol 1996.
47. Lu M, Kuroki M, Amano S, et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998; 101 : 1219-24.
48. MacDonald E, Lee WK, Hepburn S, Bell J, Scott PJW, Dominiczak MH. Advanced glycosylation end products in the mesenteric artery. Clin Chem 1992 ; 38 : 530-3.
49. Shinohara M, Thornalley PJ, Giardino I, et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation end product formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 1998 ; 101 : 1142-7.
50. Sugimoto K, Nishizawa Y, Horiuchi S, Yagihashi S. Localization in human diabetic peripheral nerve of Ne-carboxymethyllysine-protein adducts, an advanced glycation enproduct. Diabetologie 1997; 40: 1380-7.
51. Takahashi M, Hoshino H, Kushida K, Kawana K, Inoue T. Direct quantification of pentosidine in urine and serum by HPLC with column switching. Clin Cliem 1996 ; 42 : 1439-44.
52. Wrobel K, Wrobel K, Garay-Sevilla MAE, Nava LE, Malacara JM. Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system. Clin Chein 1997 ; 43:9 : 15639.
53. Munch G, Kcis R, Webels A, et al. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive Elisa. EurJ Clin Cliem Clin Biochcm 1997 ; 35 : 669-77.